OrthogenRx Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 27

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

OrthogenRx General Information

Description

Developer of knee joint pain injection designed for the treatment of musculoskeletal conditions. The company's products lubricate the joint and relieve mild to moderate knee pain for patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, enabling patients to have access to safe and non-surgical alternatives.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Devices and Supplies
Other Industries
Pharmaceuticals
Parent Company
Corporate Office
  • Doylestown Commerce Center
  • 2005 South Easton Road, Suite 207
  • Doylestown, PA 18901
  • United States
+1 (215) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OrthogenRx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OrthogenRx‘s full profile, request access.

Request a free trial

OrthogenRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of knee joint pain injection designed for the treatment of musculoskeletal conditions. The company's products
Other Devices and Supplies
Doylestown, PA
27 As of 2023
00.000
00000 0000-00-00
000000&0 00.000

000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
00000000 0000000
Edina, MN
000 As of 0000
00000
00.000 0000-00-00
000000&0 00000

00000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
00000000000 0000000
Bedford, MA
000 As of 0000
00.00
000000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OrthogenRx Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Relievant Formerly VC-backed Edina, MN 000 00000 000000&0 00000
Anika Therapeutics Formerly VC-backed Bedford, MA 000 00.00 000000000000 00.00
Ferring Pharmaceuticals Corporation Saint-Prex, Switzerland 0000
Bioventus Formerly PE-Backed Durham, NC 000 00000 000000000
Seikagaku Corporation Tokyo, Japan 0000 00000000
To view OrthogenRx’s complete competitors history, request access »

OrthogenRx Patents

OrthogenRx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4112096-A1 Intra-articular needle placement device and method of using Pending 18-Dec-2019 0000000000 0
EP-4076601-A1 Intra-articular needle placement device and method of using Pending 18-Dec-2019 0000000000
EP-4076601-A4 Intra-articular needle placement device and method of using Pending 18-Dec-2019 A61M5/486 0

OrthogenRx Executive Team (8)

Name Title Board Seat Contact Info
David Toledo-Velasquez Chief Product Development Officer
Lynne Budnovitch Senior Vice President of Operations & Compliance
J. Owens Chief Executive Officer & Board Member
You’re viewing 3 of 8 executive team members. Get the full list »

OrthogenRx Board Members (9)

Name Representing Role Since
00000 00000 OrthogenRx Board Member 000 0000
0. 00000 Self Chief Executive Officer & Board Member 000 0000
000000 00000 OrthogenRx Chairman 000 0000
You’re viewing 3 of 9 board members. Get the full list »

OrthogenRx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OrthogenRx Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OrthogenRx‘s full profile, request access.

Request a free trial

OrthogenRx FAQs

  • When was OrthogenRx founded?

    OrthogenRx was founded in 2013.

  • Who is the founder of OrthogenRx?

    Michael Daley Ph.D is the founder of OrthogenRx.

  • Who is the CEO of OrthogenRx?

    J. Owens is the CEO of OrthogenRx.

  • Where is OrthogenRx headquartered?

    OrthogenRx is headquartered in Doylestown, PA.

  • What is the size of OrthogenRx?

    OrthogenRx has 27 total employees.

  • What industry is OrthogenRx in?

    OrthogenRx’s primary industry is Other Devices and Supplies.

  • Is OrthogenRx a private or public company?

    OrthogenRx is a Private company.

  • What is the current valuation of OrthogenRx?

    The current valuation of OrthogenRx is 00000.

  • What is OrthogenRx’s current revenue?

    The current revenue for OrthogenRx is 000000.

  • How much funding has OrthogenRx raised over time?

    OrthogenRx has raised $8.05M.

  • Who are OrthogenRx’s investors?

    Ben Franklin Technology Partners of Southeastern Pennsylvania and New Age Ventures have invested in OrthogenRx.

  • Who are OrthogenRx’s competitors?

    Relievant, Anika Therapeutics, Ferring Pharmaceuticals, Bioventus, and Seikagaku are some of the 6 competitors of OrthogenRx.

  • When was OrthogenRx acquired?

    OrthogenRx was acquired on 20-Jan-2022.

  • Who acquired OrthogenRx?

    OrthogenRx was acquired by Avanos Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »